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20 years ago, advances in imaging technology have given substantial support to the study of LA complex morphology and function and to its interplay with left ventricular function. Moving from M-mode LA diameters to 2D measurements, LA volume has allowed better estimates of LA size. Accordingly, early studies tested the prognostic value of LA size, assessed mainly as LA maximal volume (LAmax), in patients with different cardiovascular diseases and in the general population ( Table 1) . The relationship to cardiovascular outcomes is expected given the fact that LA enlargement is the consequence of two factors, pressure and volume overload, which occur in a variety of cardiac disorders. In the last few years, advances in imaging techniques, such as tissue Doppler, strain, and speckle strain, have allowed the more accurate evaluation of LA function which may become a better marker of cardiovascular risk than volumes.
The left atrium has three functions across the different phases of the cardiac cycle: (i) a reservoir, storing pulmonary venous return during left ventricular (LV) systole and isovolumetric relaxation; (ii) a conduit for blood from the pulmonary veins to enter in the left ventricle in early diastole; and (iii) an active pump able to increase LV filling in late diastole. Left atrial output becomes an important determinant of LV filling when LV compliance is reduced, contributing to 38% of the stroke volume, but it decreases to 19% in restrictive LV disease. 2 In each phase of the cardiac cycle, there is a tight relationship between the left atrium and the left ventricle, so that alterations in the characteristics of one chamber may affect the other (Figure 1 ). In general, the left ventricle as the principal energy supplier is the protagonist of cardiac function and also the main factor affecting LA function and dimensions. Gupta et al. have used magnetic resonance imaging (MRI), the gold standard method in cardiac imaging, in 1802 subjects from the general population enrolled in the Dallas Heart Study with a mean age of 40 years. 3 They correctly evaluated not only the prognostic value of LA volume and function, but also the interaction of each one with LV parameters and with two specific cardiac biomarkers, cardiac troponin T and N-terminal pro brain natriuretic peptide (NT-proBNP). New imaging echo-based methods, in particular the most recent speckle tracking methods, are quicker, cheaper, and easier than MRI; however, their use in large outcome studies is hindered by the risk of low quality images, noise, and the lack of agreed common standards for this technique. Thus, to date, the study of LA function by 'classic' volumetric methods is the simplest, clinically applicable, and most representative of the interaction between dimensions and function. Volumetric parameters may be measured at different time points of the cardiac cycle allowing the calculation of LA function during each one of the three phases: filling, passive emptying, and active emptying. 4 Gupta et al.
3 estimated LA reservoir function by calculating the total emptying fraction (LAEF), which is computed from LAmax and LAmin. LAmax is more stable over time and less dependent on short-term haemodynamic changes than LAmin; LAmax increases in patients without atrial fibrillation or left heart valvular disease after a prolonged increase in pressure/volume overload, as occurs in hypertension and in heart failure, either systolic or diastolic. LAmin instead is determined by LA contractility and by the LA load which depends in part on passive LV properties (i.e. the movement of the mitral annulus away from the apex into the left atrium) and on pulmonary capacitance, since retrograde flow occurs backwards into the pulmonary veins. LAEF, being the result of many variables, may be a marker of outcomes more sensitive than LA size, as shown in the study of Gupta et al.
It is well known that hypertension and obesity (two important factors promoting a reduction of LV compliance) are more common in Afro-Americans than in other ethnicities, and this is the first study using good cardiac imaging in a general population of which about half were black.
Gupta and collaborators are to be congratulated for making available their data which will be a benchmark for future studies aimed at a better understanding of the prognostic roles of LA size and function and of the interplay with LV structure and function.
In Editorial potentially allowing for early detection and for an estimate of its duration. As biomarkers, LA size and, more so, LA function somewhat resemble circulating cardiac biomarkers (i.e. natriuretic peptides and cardiac troponins) which reflect alterations in the whole heart. Accordingly, the study of Gupta et al. shows that the contribution of LA variables (LAEF in particular) provided a significant but small increment in discrimination of all-cause mortality, when cardiac troponin was already in the model. Whether LA dimensions and function can also be therapeutic targets and not only markers of risk is a largely unexplored area and deserves future research.
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